FIELD: pharmacy, oncology. SUBSTANCE: invention proposes new agent for oncological sicknesses treatment. Agent is a complex of organocobalt (III) with Schiff's tridentate bases of the general formula (I) . This compound enhances effectiveness of the known methods of antitumor therapy and ensures to decrease dosage of cytopathic drugs significantly or intensity of physical effects. EFFECT: enhanced effectiveness of agent. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBINED TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER USING THERMOCHEMI-RADIOTHERAPY | 2017 |
|
RU2654612C1 |
METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
METHOD FOR PREDICTION OF LOCAL POSTOPERATIVE RECURRENCES IN PATIENTS WITH BREAST CANCER | 2014 |
|
RU2540168C1 |
METHOD OF COMBINATION TREATMENT OF LOCALLY ADVANCED RECTAL CANCER | 2010 |
|
RU2447914C1 |
METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
METHOD FOR COMBINED TREATMENT OF STAGE II-III NON-SMALL-CELL LUNG CANCER | 2017 |
|
RU2636869C1 |
COMBINATION THERAPY OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2372901C2 |
SHF EMITTER FOR HEATING HUMAN BODY TISSUES | 2006 |
|
RU2324509C2 |
METHOD FOR INTERSTITIAL, HIGH-POWER BRACHYTHERAPY OF LOCALLY ADVANCED SMALL PELVIS TUMORS HAVING A LATERAL INVASION OF A SMALL PELVIS WALL | 2019 |
|
RU2719935C2 |
ANTI-TUMOR AGENT BENZAMIDE | 2003 |
|
RU2257894C1 |
Authors
Dates
1998-05-27—Published
1995-02-23—Filed